多囊卵巢综合征与中年期肌肉骨骼健康结局的关系:一项纵向队列研究
研究纳入409名已生育女性,随访17年,按诊断多囊卵巢综合征(PCOS,n=26)、可能PCOS(n=41)和无PCOS(n=342)分组。中年期评估显示,诊断和可能PCOS与脊柱和髋部骨密度较高及CTX-1较低相关,在绝经后女性中尤为明显,且独立于体脂。
要点
- 诊断和可能PCOS与中年期脊柱和髋部骨密度较高相关,且独立于全身脂肪量。
- PCOS与骨转换标志物CTX-1较低相关,提示骨转换水平较低。
- 按绝经状态分层,PCOS与脊柱和髋部骨密度的关联仅见于绝经后女性。
核心结论
- 中年期PCOS与脊柱和髋部骨密度呈正相关,与骨转换标志物CTX-1呈负相关,且独立于体脂,尤其在绝经后更为明显。
研究设计与样本
- 前瞻性队列研究,纳入409名已生育女性,随访17年,随访第3年分为诊断PCOS(n=26)、可能PCOS(n=41)和无PCOS(n=342)。
- 第17年医院访视时采用双能X线吸收法、I型前胶原N端前肽(P1NP)和I型胶原C端肽(CTX-1)评估肌肉骨骼健康结局,采用线性回归分析关联。
主要发现
- 中年期访视时平均(标准差)年龄为51(5)岁,409名女性中177名(43%)已绝经。
- 年龄校正分析中,诊断和可能PCOS与脊柱骨密度较高(0.05 [0.01, 0.09] g/cm2)和髋部骨密度较高(0.05 [0.01, 0.08] g/cm2)相关,与CTX-1较低(-13.7 [-23.7, -2.5] %)相关。
- 进一步校正中年期全身脂肪量后,PCOS仍与脊柱骨密度(0.04 [0.00, 0.08] g/cm2)、髋部骨密度(0.04 [0.01, 0.07] g/cm2)和CTX-1(-13.0 [-23.0, -1.8] %)相关。
- 按中年期绝经状态分层,PCOS与脊柱骨密度(0.09 [0.02, 0.16] g/cm2)和髋部骨密度(0.07 [0.02, 0.13] g/cm2)的关联仅见于绝经后女性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is polycystic ovary syndrome (PCOS) associated with adverse musculoskeletal outcomes during the menopausal transition? DESIGN: Parous women (n = 409) were enrolled from Project Viva, a prospective cohort study, and followed for 17 years. Women were classified as 'diagnosed PCOS' (n = 26) 3 years after enrolment; 'probable PCOS' (n = 41), based on the presence of two or more PCOS traits; and 'no PCOS' (n = 342). Musculoskeletal health outcomes were assessed by dual-energy X-ray absorptiometry, procollagen type I N-propeptide (P1NP) and C-terminal telopeptide of type I collagen [CTX-1] at a hospital visit at 17 years. Associations were evaluated using linear regressions. RESULTS: At the mid-life visit, mean (SD) age was 51 (5) years, and 177 out of 409 (43%) women had reached menopause. Diagnosed and probable PCOS was associated with higher BMD at spine (0.05 [0.01, 0.09] g/cm2) and hip (0.05 [0.01, 0.08] g/cm2) but with lower CTX-1 (-13.7 [-23.7, -2.5] %) in age-adjusted analyses. After midlife whole-body fat mass adjustment, PCOS remained associated with spine (0.04 [0.00, 0.08] g/cm2) and hip BMD (0.04 [0.01, 0.07] g/cm2) and CTX-1 (-13.0 [-23.0, -1.8] %). Models adjusting for BMI versus fat mass showed similar results, although some confidence intervals included null values. When stratified by midlife menopausal status, PCOS was associated with spine (0.09 [0.02, 0.16] g/cm2) and hip (0.07 [0.02, 0.13] g/cm2) BMD only among post-menopausal women. CONCLUSIONS: PCOS is positively correlated to BMD (spine, hip) and inversely associated with bone turnover (CTX-1) in mid-life, independent of body fat, particularly after the menopause.
引用
- Kazemi M, Rifas-Shiman SL, Yu EW, et al. Polycystic ovary syndrome in relation to musculoskeletal health outcomes during midlife: a longitudinal cohort study. Reprod Biomed Online. 2025. PMID: 40934620. doi:10.1016/j.rbmo.2025.105068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。